Gene expression profile analysis by DNA microarrays: A new approach to assess functional genomics in diseases

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 19, Issue 1, 2002, Pages 5-9

  Agostini, Carlo ^a   Miorin, Marta ^a   Semenzato, Gianpietro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Genomics; Interstitial lung disease; Microarray; Proteomics; Sarcoidosis

Indexed keywords

DNA;

DISEASE CLASSIFICATION; DNA MICROARRAY; GENOMICS; HUMAN; INTERNET; INTERSTITIAL LUNG DISEASE; LUNG SARCOIDOSIS; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

GENE EXPRESSION PROFILING; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 0036214493     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. A map of human genome sequence variation containing 1.42 million single nucleolide polymorphisms
2. A physical map of the human genome
3. The sequence of the human genome
4. Facts and controversies in the classification of idiopathic interstitial pneumonias
5. Expression of sarcoidosis related genes in lung lavage cells
6. Functional genomics in sarcoidosis-reduced or increased apoptosis?
7. Gene expression patterns in lungs of patients with primary pulmonary hypertension: A gene microarray analysis
8. Genomic approaches to research in pulmonary hypertension
9. DNA chips: State-of-the art
10. Microarrays under the microscope
11. Gene expression microarrays and the integration of biological knowledge
12. Moleculur monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling
13. Functional genomics of oxidant-induced lung injury
14. Interstitial lung diseases: What next?
15. Analysis of gene polymorphisms in interleukin-10 and transforming growth factor-beta I in sarcoidosis
16. Vitamin D receptor gene polymorphism and calcium metabolism in sarcoidosis patients
17. Evidence for disease phenotype associated haplotypes (DR.TNF) in sarcoidosis
18. Extended genetic alterations in a patient with pulmonary surcoidosis, a benign disease
19. Sarcoidosis genes and microbes-soil or seed?
20. Cytokine and chemokine blockade as immunointervention strategy for the treatment of diffuse lung diseases